Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury.

The Journal of biological chemistry

Volumn 277, Issue 33, 2002, Pages 30128-30136

  Han, Byung Hee ^a   Xu, Daigen ^a   Choi, Junjeong ^a   Han, Yongxin ^a   Xanthoudakis, Steven ^a   Roy, Sophie ^a   Tam, John ^a   Vaillancourt, John ^a   Colucci, John ^a   Siman, Robert ^a   Giroux, Andre ^a   Robertson, George S ^a   Zamboni, Robert ^a   Nicholson, Donald W ^a   Holtzman, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASP3 PROTEIN, RAT; CASPASE; CASPASE 3; CYSTEINE PROTEINASE INHIBITOR; M 826 COMPOUND; NEUROPROTECTIVE AGENT; OXADIAZOLE DERIVATIVE; PYRAZINE DERIVATIVE;

ANIMAL; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; DRUG ANTAGONISM; HYDROLYSIS; NEWBORN; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CASPASE 3; CASPASES; CYSTEINE PROTEINASE INHIBITORS; HYDROLYSIS; HYPOXIA-ISCHEMIA, BRAIN; NEUROPROTECTIVE AGENTS; OXADIAZOLES; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0242663945     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M202931200     Document Type: Article

References (0)